Pfizer, Inc. (NYSE:PFE)

CAPS Rating: 4 out of 5

A research-based pharmaceutical company, Pfizer discovers, develops, manufactures, and markets prescription medicines such as Lipitor, Celebrex, and Viagra.

Results 1 - 20 of 988 : 1 2 3 4 5 6 7 8 9 10 Next »

Recs

0
Member Avatar sarre9 (< 20) Submitted: 6/12/2013 8:42:07 PM : Outperform Start Price: $28.37 PFE Score: +1.47

Divestiture of Zoetis and subsequent retirement of PFE stock will have a net positive effect on share price.

Recs

0
Member Avatar watersports2001 (58.10) Submitted: 6/6/2013 9:14:36 PM : Outperform Start Price: $28.24 PFE Score: +3.29

I think positive with this stock and that it will grow whether people go to zts or not. If you've got some.mind to play with ,this should be a good choice

Recs

0
Member Avatar rossnr3 (46.70) Submitted: 6/4/2013 9:49:23 AM : Outperform Start Price: $27.99 PFE Score: +4.80

Selling animal & nutrition businesses; using fund for stock buyback and expand pipeline.

Recs

0
Member Avatar Snugglah (< 20) Submitted: 5/7/2013 12:20:49 PM : Outperform Start Price: $28.55 PFE Score: +0.88

new drugs & baby boomers - I think this is a winning combination.

Recs

0
Member Avatar jen2gan (< 20) Submitted: 5/1/2013 12:46:20 PM : Outperform Start Price: $28.74 PFE Score: -2.04

y

Recs

0
Member Avatar DrGoldin (98.46) Submitted: 4/23/2013 10:59:17 PM : Outperform Start Price: $30.82 PFE Score: -9.15

I'm seriously late to this party, but the forward p/e is STILL less than 14.

Recs

0
Member Avatar itsthedudeguy (30.13) Submitted: 4/9/2013 10:51:44 AM : Outperform Start Price: $28.86 PFE Score: -3.82

div + growth = buy

Recs

0
Member Avatar andrewstrate (64.61) Submitted: 4/5/2013 2:12:45 AM : Outperform Start Price: $28.72 PFE Score: -4.85

Go Kalamazoo they are creating bigger dicks everyday! Those people are always seeming to win.

Recs

0
Member Avatar robotclo (27.77) Submitted: 3/19/2013 2:12:12 AM : Outperform Start Price: $27.87 PFE Score: -0.83

Good year for health care

Recs

1
Member Avatar DrMag (44.57) Submitted: 3/14/2013 2:15:15 PM : Outperform Start Price: $27.75 PFE Score: +0.39

Very undervalued; new products just reaching the stage to come to market.

Recs

0
Member Avatar cyruswindsong (< 20) Submitted: 3/12/2013 10:09:31 PM : Outperform Start Price: $27.69 PFE Score: +0.09

becuse of the rise of bad health issues and obeisity in the world. diabetis is on the rise. Pfizer is searching for better meds. for the masses. so now they give us "Afrezza" a new inhaleable insulin for diabetis.....a promising new med.

Recs

0
Member Avatar djohn1969 (< 20) Submitted: 3/12/2013 1:53:19 AM : Outperform Start Price: $19.89 PFE Score: +26.15

Hmmmm. I don't hear so much of all that "pipeline cliff" noise pundits were talking about Pfizer a couple years ago. A strong pipeline and big deals mean Pfizer will continue to say pffffft to the silly pipeline cliff talk.

Recs

0
Member Avatar jalalaram333 (< 20) Submitted: 3/11/2013 8:02:07 PM : Outperform Start Price: $28.00 PFE Score: -0.89

Pfizer managed Lipitor's LOE well and learend to diversify on multiple successful medicines. It is constantly reshuffling and reinventing its management and portfolio. Publicly known data show upwards activity for new drug indications and new drugs targeted for approval soon.

Recs

0
Member Avatar IfHeDiesHeDies (59.33) Submitted: 3/8/2013 4:16:13 PM : Outperform Start Price: $27.93 PFE Score: -1.03

A+

Recs

0
Member Avatar bsmiling22 (< 20) Submitted: 2/25/2013 7:17:56 PM : Outperform Start Price: $26.67 PFE Score: -0.05

great co lots of pipeline

Recs

0
Member Avatar JorgeAura (< 20) Submitted: 2/2/2013 4:43:28 PM : Underperform Start Price: $27.14 PFE Score: +1.53

Dowjones in maximums.

Recs

0
Member Avatar bclan13 (99.31) Submitted: 1/24/2013 12:50:09 AM : Underperform Start Price: $26.42 PFE Score: -0.56

I'm not sure what earnings growth is expected but I don't understand why there would be. I understand the dividend but when bond yields rise pharma sector is going to get knocked in the mouth.

Recs

0
Member Avatar john603 (42.02) Submitted: 1/9/2013 12:45:39 AM : Outperform Start Price: $25.78 PFE Score: +0.83

Great yield good chart pattern Chamer chart talk

Recs

0
Member Avatar judysway (52.56) Submitted: 1/8/2013 8:02:21 AM : Outperform Start Price: $25.56 PFE Score: +1.66

Pfizer is helping to fund research for Organovo, I believe their connection will be profiting both companies.

Recs

0
Member Avatar befoolin (< 20) Submitted: 12/12/2012 11:25:00 AM : Outperform Start Price: $24.50 PFE Score: +2.63

My favorite drug...play

Featured Broker Partners


Advertisement